Toggle navigation
Home
Magazine
Current Issue
Past Issues
Digital Edition
About Us
Featured Sections
Executive Interviews
The Enterprisers
Companies To Watch
Capitol Perspectives
Industry Leader
CEO Corner
Industry Explorers
Leadership Lessons
Ask The Board
Industry Research
Industry Topics
Clinical Trials
Finance-Funding
Outsourcing
Regulatory
Research & Development
Blogs
Chief Editor Rob Wright
Executive Editor's Blog
Events
Outsourced Pharma Events
CMO Leadership Awards
CRO Leadership Awards
Subscribe
Subscribe / Renew
Change Subscription
Cancel Subscription
Newsletter Subscription
Magazine Issue
October 2010 Issue Table Of Contents
Source: Life Science Leader
Editor’s Note
What’s With All The Weed?
Feature
Orphan Drugs: Big Pharma’s Next Act?
The Challenges Of Bringing A Cannabis-Based Drug To Market
Inside The Industry
The Development Of Injectable Bioproducts: The Perfect Three-Step Waltz
Is It Time To Retool To Single-Use?
Quick Response Manufacturing: Taking The Pharmaceutical Industry Beyond Lean Six Sigma
M&A And The Pharma Supply Chain: Avoiding Critical Disruptions
Zinc Fingers Point The Way
The High Stakes Of Running A Successful Oncology Trial
Six Insurance Gaps Pharma/Biotech Companies Should Avoid
Improving Market Access Across Europe
Building A Culture Of FCPA Compliance
Industry Leader
Determining Security Capabilities Of Ground Transportation Companies
Newsletter Signup
Get the latest articles from Life Science Leader delivered to your inbox.
I agree to the
Terms
and
Privacy Statement
.
SIGN ME UP
YOU MAY ALSO LIKE...
×
Contact Details
Company Name
Life Science Leader
Address
5340 Fryling Rd. , Suite 300
Erie, PA 16510-4672
US
Phone
814-897-9000
Company Profile
Email Us
